After I sold TOMS Shoes for $400 million I was misdiagnosed with bipolar disorder — and it almost cost me everything
Most people land in a psychiatrist’s office because something happened: a loss, a breakup, the end of a career.
The founder of TOMS Shoes, Blake Mycoskie, recently shared a personal and cautionary tale about the potential pitfalls of a hasty psychiatric diagnosis. After selling his company for $400 million, he was misdiagnosed with bipolar disorder, which he claims nearly cost him his fortune, relationships, and overall well-being. This story highlights the importance of accurate diagnosis and the potential consequences of mislabeling someone with a mental health condition.
Mycoskie's experience is a reminder that high-stakes situations, such as a major business transaction, can be emotionally taxing and may lead to misinterpretation of symptoms. The intersection of mental health and finance is complex, and this anecdote underscores the need for careful consideration and thorough evaluation in such cases. It also raises questions about the role of psychiatrists and medical professionals in high-pressure situations.
As Mycoskie moves forward, it will be interesting to see how he uses his experience to advocate for more accurate diagnoses and better support systems for entrepreneurs and high-net-worth individuals. The business and finance communities will be watching to see how he leverages his platform to promote greater awareness and understanding of mental health issues, and whether his story leads to changes in how psychiatric diagnoses are approached in high-stakes situations.
Originally reported by marketwatch.com. FundingWire adds analysis for finance & markets readers.